Cargando…

Monitoring of Cyclosporine A Blood Levels in Clinical Settings

Detalles Bibliográficos
Autor principal:	Niemczyk, Mariusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2012
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614269/ https://www.ncbi.nlm.nih.gov/pubmed/23573477 http://dx.doi.org/10.5812/numonthly.2701

Ejemplares similares

Dyslipidemia in Renal Transplant Recipients Treated With Cyclosporine A
por: Niemczyk, Mariusz
Publicado: (2013)

Cosmetically Disfiguring Side Effects of Cyclosporine
por: Panicker, Vinitha Varghese, et al.
Publicado: (2012)

Cyclosporine Effects on Pediatric Kidney Recipients
por: Hami, Maryam
Publicado: (2012)

Cyclosporine Drug Levels: Comparison of the Architect 1000i with the Siemens Dimension RXL System
por: Chavan, Preeti, et al.
Publicado: (2015)

Monitoring Cyclosporine Absorption: A Step Beyond Therapeutic Drug Monitoring
por: Lee, Po-Chang
Publicado: (2012)

No Association Between Cyclosporine Levels and Dyslipidemia?
por: Filler, Guido
Publicado: (2014)

Effect of Erdosteine on Cyclosporine Induced Chronic Nephrotoxicity
por: Briguori, Carlo, et al.
Publicado: (2012)

Bioequivalence study of cyclosporine in renal transplant recipients
por: Gautam, Gagan
Publicado: (2007)

Lichen striatus successfully treated with oral cyclosporine
por: Romita, Paolo, et al.
Publicado: (2017)

Cyclosporine A at Reperfusion Reduces Infarct Size in Pigs
por: Skyschally, Andreas, et al.
Publicado: (2010)

Cyclosporine has a potential role in the treatment of SARS
por: Russell, Clark D., et al.
Publicado: (2013)

Gingival enlargement due to Cyclosporine A therapy in aplastic anaemia
por: Sabnis, Girish R., et al.
Publicado: (2011)

Sturge–Weber syndrome coexisting with autosomal dominant polycystic kidney disease
por: Niemczyk, Mariusz, et al.
Publicado: (2012)

Insights into the Possible Mechanism of Cyclosporine-Induced Chronic Nephrotoxicity; Arteriolopathy
por: Yoon, Sang Pil
Publicado: (2012)

Still the Joker in the Pack: When to Take Out Cyclosporine in the Game?
por: Resál, Tamás, et al.
Publicado: (2021)

Is the interaction between ticlopidine and cyclosporin dose related? Report of three cases
por: Houssaïni, Tarik Sqalli, et al.
Publicado: (2010)

A Pediatric Patient with Intravenous Cyclosporine Anaphylaxis Who Tolerated the Oral Form
por: Işık, Pamir, et al.
Publicado: (2014)

Cyclosporine-Induced Posterior Reversible Encephalopathy Syndrome in a Patient with Pemphigus Vulgaris
por: Park, So Eun, et al.
Publicado: (2015)

Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia()
por: Sanchez-Pernaute, Olga, et al.
Publicado: (2021)

Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia()
por: Sanchez-Pernaute, Olga, et al.
Publicado: (2021)

A Case of Kaposi's Varicelliform Eruption in a Patient with Psoriasis Receiving Cyclosporine Therapy
por: Külcü Çakmak, Seray, et al.
Publicado: (2015)

Prospective analysis of utility and feasibility of ambulatory blood pressure monitoring service in a pediatric nephrology set up
por: Sinha, R.
Publicado: (2013)

Comparison of oscillometric blood pressure measurement by two clinical monitors
por: Prashanth, GP
Publicado: (2011)

Health-Related Quality of Life in Kidney Transplant Recipients
por: Niemczyk, Mariusz
Publicado: (2013)

A Case of Cyclosporine-Induced Sebaceous Hyperplasia in a Renal Transplant Patient Successfully Treated with Isotretinoin
por: Jung, Hwa Young, et al.
Publicado: (2016)

Dyslipidemia After Kidney Transplantation and Correlation With Cyclosporine Level: A Glimpse into the Future
por: Ahmed, Mohamed H.
Publicado: (2013)

Long-term outcome following cyclosporine-related neurotoxicity in paediatric allogeneic haematopoietic stem cell transplantation
por: Straathof, K, et al.
Publicado: (2017)

Toxic epidermal necrolysis in an 8-year-old girl successfully treated with cyclosporin A, intravenous immunoglobulin and plasma exchange
por: Zielińska, Marzena, et al.
Publicado: (2018)

Monitoring strategy as a tool for blood transfusion safety
por: Daltoé, Tiago, et al.
Publicado: (2011)

Cyclosporine A and COVID-19 – The COQUIMA cohort
por: Schuurmans, Macé M., et al.
Publicado: (2020)

Cyclosporine A and COVID19 – The COQUIMA cohort
por: Sánchez-Pernaute, Olga
Publicado: (2020)

Effect of percutaneous renal denervation on blood pressure level and sympathetic activity in a patient with polycystic kidney disease
por: Prejbisz, Aleksander, et al.
Publicado: (2013)

Malondialdehyde Level in the Cord Blood
por: Joob, Beuy, et al.
Publicado: (2012)

Dorsal radial artery catheterization for invasive blood pressure monitoring
por: Nunes, Roosevelt Santos, et al.
Publicado: (2020)

Telephonic monitoring of patients on clozapine in the resource-poor setting during the COVID-19 pandemic
por: Grover, Sandeep, et al.
Publicado: (2020)

Non-Invasive Continuous Cerebrovascular Monitoring for Subacute Bedside and Outpatient Settings: An Important Advancement
por: Gomez, Alwyn, et al.
Publicado: (2021)

10/10 Accuracy Analysis of a Self-Monitoring Blood Glucose System
por: Katz, Laurence B, et al.
Publicado: (2021)

Monitoring endotracheal tube cuff pressure using a blood pressure manometer
por: Bloria, Summit, et al.
Publicado: (2022)

Ambulatory Blood Pressure Monitoring and Body Mass Index: Good but Not Standardized!
por: Ünlü, Murat, et al.
Publicado: (2015)

Cyclosporine A and COVID19 – The COQUIMA cohort – Author's reply
por: Guisado-Vasco, Pablo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0jnr99l7snav68onoo62nljti1